Profile: Osiris Therapeutics, Inc. is a stem cell therapeutic company focused on developing & marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. We are committed to developing our proprietary adult stem cell technology in order to provide physicians with next-generation tools for the treatment and functional restoration of damaged or diseased tissues. The multi-potential character of our stem cell product candidates, provides the basis for a cell therapy platform that represents a virtually limitless number of indications. Some of our products are prochymal GvHD, prochymal cardiac, prochymal diabetes and chondrogen. Our product, prochymal is developed to treat immune conditions such as graft versus host disease (GvHD), and Crohn's disease to reduce inflammation, & repair damaged tissue. Chondrogen™ repairs damaged meniscus tissue and prevents the progression of arthritis.